Anchor the drug.
Transform the medicine.

Our membrane-anchored drug design (MADD) platform links a pharmacophore to a membrane-mimicking kinetophore that lodges the molecule in the lipid bilayer, enabling unprecedented control of drug distribution and exceptional specificity for cell-surface targets—taming powerful pharmacophores for precise site of action and unlocking a new class of safer and more effective drugs.